Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin for CIN prevention in coronary angiography
NCT02113540Phase 3Unknown
- Start
- Jan 2012
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of atorvastatin in contrast-induced nephropathy (CIN). Status: unknown.
02
Drugs
atorvastatin
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on NCT02113540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02113540.